BWAY Brainsway Ltd. ADRs

BrainsWay is dedicated to developing and providing advanced technology solutions for the treatment of a variety of brain disorders. The company was established in 2003, and became a public company traded on the Tel-Aviv Stock Exchange in January 2007.  This is an ADR of a company whose stock trades outside of the U.S. as the symbol IT:BRIN.

$7.11  -0.76 (-9.66%)
As of 12/03/2021 15:40:20 EST     IEX book   CBOE book

Security Information
Category1:  US Equity
Category2:  ADRs
Category3:  Micro cap
GICS sector:  Information Technology
Industry:  Diagnostics & Research
Index country:  Israel
Country of incorporation:  
IPO date:  04/17/2019
Outstanding shares:  16,451,817
Average volume:  27,170
Market cap:   $129,475,800
Current dividend yield:  0.00%
All SEC filings:   SEC Edgar Online
Annual filings:      20-F
CUSIP:    10501L106
ISIN:        US10501L1061
Valuation   (See tab for details)
PE ratio:   -16.96
PB ratio:   1.92
PS ratio:   4.58
Return on equity:   -11.80%
Net income %:   -24.34%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy